eMJA: Articles on Drugs and alcohol

eMJA The Medical Journal of Australia

Articles on Drugs and alcohol

140 articles

Patterns and incidence of γ-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria [Research] Paul M Dietze, Stefan Cvetkovski, Monica J Barratt and Susan Clemens Med J Aust 2008; 188 (12): 709-711.
Heavy cannabis use and depressive symptoms in three Aboriginal communities in Arnhem Land, Northern Territory [Addressing Diseases Of Disadvantage &mda] K S Kylie Lee, Alan R Clough, Muriel J Jaragba, Katherine M Conigrave and George C Patton Med J Aust 2008; 188 (10): 605-608.
Intervening early to reduce developmentally harmful substance use among youth populations [Letters] Vania Modesto-Lowe, Nancy M Petry and Melissa McCartney Med J Aust 2008; 188 (8): 494-495.
Unplanned admissions to two Sydney public hospitals after naltrexone implants [Research] Nicholas Lintzeris, Soung Lee, Lucinda Scopelliti, James Mabbutt and Paul S Haber Med J Aust 2008; 188 (8): 441-444.
Ensuring the safety of new medications and devices: are naltrexone implants safe? [Editorials] Alex D Wodak, Robert Ali, David Henry and Lloyd Sansom Med J Aust 2008; 188 (8): 438-439.
Fatal paramethoxy-amphetamine (PMA) poisoning in the Australian Capital Territory [Letters] Paul G Lamberth, Geoff K A Ding and Liisa A Nurmi Med J Aust 2008; 188 (7): 426-426.
Wa! Ningeningma arakba akina da! (Oh! Now I know, that’s it!) [Viewpoint] K S Kylie Lee, Muriel J Jaragba, Alan R Clough and Katherine M Conigrave Med J Aust 2008; 188 (2): 113-116.
High levels of cannabis use persist in Aboriginal communities in Arnhem Land, Northern Territory [Letters] K S Kylie Lee, Alan R Clough and Katherine M Conigrave Med J Aust 2007; 187 (10): 594-595.
High levels of cannabis use persist in Aboriginal communities in Arnhem Land, Northern Territory [Letters] K S Kylie Lee, Alan R Clough and Katherine M Conigrave Med J Aust 2007; 187 (10): 594-595.
Comparison of crystalline methamphetamine (“ice”) users and other patients with toxicology-related problems [Research] Philippa J Bunting, Gordian W O Fulde and S Lesley Forster Med J Aust 2007; 187 (10): 564-566.
Comparison of crystalline methamphetamine (“ice”) users and other patients with toxicology-related problems [Research] Philippa J Bunting, Gordian W O Fulde and S Lesley Forster Med J Aust 2007; 187 (10): 564-566.
Beliefs of young people and their parents about the harmfulness of alcohol, cannabis and tobacco for mental disorders [Research] Dan I Lubman, Leanne Hides and Anthony F Jorm Med J Aust 2007; 187 (5): 266-269.
Opioid overdose deaths can occur in patients with naltrexone implants [Matters Arising] Amy E Gibson, Louisa J Degenhardt and Wayne D Hall Med J Aust 2007; 187 (1): 56-57.
Opioid overdose deaths can occur in patients with naltrexone implants [Matters Arising] Nikolaj Kunøe and Helge Waal Med J Aust 2007; 187 (1): 56.
Opioid overdose deaths can occur in patients with naltrexone implants [Matters Arising] Eric Khong and Winston Choy Med J Aust 2007; 187 (1): 56.
Opioid overdose deaths can occur in patients with naltrexone implants [Matters Arising] Robert G Batey Med J Aust 2007; 187 (1): 55.
Opioid overdose deaths can occur in patients with naltrexone implants [Matters Arising] Colin L Brewer Med J Aust 2007; 187 (1): 55.
Opioid overdose deaths can occur in patients with naltrexone implants [Matters Arising] Gary K Hulse and Robert J Tait Med J Aust 2007; 187 (1): 54.
Opioid overdose deaths can occur in patients with naltrexone implants [Matters Arising] Moira G-B Sim Med J Aust 2007; 187 (1): 54.
Alcohol and hepatitis C [Viewpoint] John M Duggan and Anne E Duggan Med J Aust 2007; 187 (1): 47-48.
“Meth mouth” [Letters] Anne-Marie L Laslett and John N Crofts Med J Aust 2007; 186 (12): 661.
Prisons, hepatitis C and harm minimisation [Viewpoint] Michael H Levy, Carla Treloar, Rodney M McDonald and Norman Booker Med J Aust 2007; 186 (12): 647-649.
A review of policies on alcohol use during pregnancy in Australia and other English-speaking countries, 2006 [Public Health] Colleen M O'Leary, Louise Heuzenroeder, Elizabeth J Elliott and Carol Bower Med J Aust 2007; 186 (9): 466-471.
Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia [Research] Louisa Degenhardt, Amanda Roxburgh and Rebecca McKetin Med J Aust 2007; 186 (7): 342-345.
Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation [Research] Suzanne D Gray, Daniel M Fatovich, David L McCoubrie and Frank F Daly Med J Aust 2007; 186 (7): 336-339.
Homicide during psychotic illness in New South Wales between 1993 and 2002 [Research] Olav B Nielssen, Bruce D Westmore, Matthew M B Large and Robert A Hayes Med J Aust 2007; 186 (6): 301-304.
Opioid overdose deaths can occur in patients with naltrexone implants [Notable Cases] Amy E Gibson, Louisa J Degenhardt and Wayne D Hall Med J Aust 2007; 186 (3): 152-153.
National guidelines on alcohol use during pregnancy: a dissenting opinion [For Debate] John S Whitehall Med J Aust 2007; 186 (1): 35-37.
Promoting community awareness of the link between illicit drugs and mental disorders [Editorials] Anthony F Jorm and Dan I Lubman Med J Aust 2007; 186 (1): 5-6.
Assessing the wisdom of funding DrinkWise [Modern Lifestyle — Editorial] Wayne D Hall and Robin Room Med J Aust 2006; 185 (11/12): 635-636.
Inhalant misuse in youth: time for a coordinated response [Viewpoint] Dan I Lubman, Leanne Hides and Murat Yücel Med J Aust 2006; 185 (6): 327-330.
“Meth mouth” [Snapshot] Kishore Shetty Med J Aust 2006; 185 (5): 292.
“Meth mouth” [Snapshot] Kishore Shetty Med J Aust 2006; 185 (5): 292.
Substance misuse in patients with acute mental illness [Letters] Cherrie Ann Galletly and Darryl P Watson Med J Aust 2006; 184 (12): 645.
National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia [Public Health] Adam R Winstock, Caroline M Anderson and Janie Sheridan Med J Aust 2006; 184 (11): 560-562.
Action is required to reduce kava supply in Arnhem Land . . . again! [Letters] Alan R Clough, Bart J Currie, Maymuna W Yunupingu and Katherine M Conigrave Med J Aust 2006; 184 (2): 91-92.
Adolescent alcohol problems: whose responsibility is it anyway? [Risky Times - Update] Yvonne A Bonomo Med J Aust 2005; 183 (8): 430-432.
Hypophosphataemia secondary to oral refeeding syndrome in a patient with long-term alcohol misuse [Lessons from Practice] Adrian T Fung and Janet Rimmer Med J Aust 2005; 183 (6): 324-326.
Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose [Letters] Ariella Glaser, Dwight Arakaki, Gar Ming Chan and Robert S Hoffman || Anne-Maree Kelly, Debra Kerr and Paul Dietze Med J Aust 2005; 182 (8): 427-429.
Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species [Letters] Craig A Aboltins, Penny Allen and John R Daffy Med J Aust 2005; 182 (8): 427.
Prescription shoppers line [Letters] Max Kamien Med J Aust 2005; 182 (5):255.
Reducing drug-related harm: Australia leads the way [Letters] David G E Caldicott and Cameron Duff || Alison J Ritter, Alex D Wodak and J Nick Crofts Med J Aust 2005; 182 (3):140-141.
A case of desquamating rash associated with methadone use [Notable cases] Natalie Kordjian, Annabelle D Donaldson, Dedee F Murrell and Steven A Krilis Med J Aust 2005; 182 (2): 76-77.
A syndromic rash in patients attending methadone clinics in New South Wales [Notable cases] Jon N Currie, Lucinda Wallman, Jimmy Chien, Lisa Snell, Margaret Cluff, Karen Scrivener and Elizabeth M Benson Med J Aust 2005; 182 (2): 73-75.
Correction: The hidden tragedy of offender deaths [Correction] Stuart Ross Med J Aust 2005; 182 (1): 48.
Audit of prescribed nicotine replacement therapy to hospital inpatients who smoke [Letters] Barbara A Hawkshaw and Yeqin Zuo Med J Aust 2005; 182 (1): 43-44.
Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose [Research] Anne-Maree Kelly, Debra Kerr, Paul Dietze, Ian Patrick, Tony Walker and Zeff Koutsogiannis Med J Aust 2005; 182 (1): 24-27.
The effect of a reduction in heroin supply on fatal and non-fatal drug overdoses in New South Wales, Australia [Research] Louisa J Degenhardt, Elizabeth Conroy, Stuart Gilmour and Wayne D Hall Med J Aust 2005; 182 (1): 20-23.
The effect of a reduction in heroin supply on fatal and non-fatal drug overdoses in New South Wales, Australia [Research] Louisa J Degenhardt, Elizabeth Conroy, Stuart Gilmour and Wayne D Hall Med J Aust 2005; 182 (1): 1-4.
A syndromic rash in patients attending methadone clinics in New South Wales [Letters] Vernon J Heazlewood || Rodney D Sinclair || Jon N Currie, Lisa Snell and Elizabeth M Benson Med J Aust 2005; 12 (182): 653-654.
The hidden tragedy of offender deaths [Editorials] Stuart Ross Med J Aust 2004; 181 (9): 469-470.
Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances [Supplement · Depression: reducing t] Jane M Burns, Raymond F Martyres, Danielle Clode and Jennifer M Boldero Med J Aust 2004; 181 (7 Suppl): S25-S28.
Helping addicted colleagues [Doctors’ Health & Lifestyle &n] Stephen M Jurd Med J Aust 2004; 181 (7): 400-402.
Epidemic of gamma-hydroxybutyrate (GHB) ingestion [Letters] T C K Brown Med J Aust 2004; 181 (6): 343.
Doctor shoppers”: at risk by any other name [Letters] A Rod MacQueen || John M Hart || Jeff Whalan Med J Aust 2004; 181 (6): 342.
Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia [Research] David G E Caldicott, Fiona Y Chow, Brian J Burns, Peter D Felgate and Roger W Byard Med J Aust 2004; 181 (6): 310-313.
The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Au [Research] Courtney L Breen, Louisa J Degenhardt, Raimondo B Bruno, Amanda D Roxburgh and Rebecca Jenkinson Med J Aust 2004; 181 (6): 300-304.
Reducing drug-related harm: Australia leads the way [Conference Report] Alison J Ritter, Alex D Wodak and J Nick Crofts Med J Aust 2004; 181 (5): 242-243.
Using AUDIT to classify patients into Australian Alcohol Guideline categories [Letters] Julia E Fawcett, Anthony P Shakeshaft, Mark F Harris, Alex Wodak, Richard P Mattick and Robyn L Richmond Med J Aust 2004; 180 (11): 598.
Risk-taking behaviour of young women in Australia: screening for health-risk behaviours [Letters] Gordon Broderick Med J Aust 2004; 180 (10): 544.
Is lawful discrimination against illicit drug users acceptable? [For Debate] Alex D Wodak, Philip A Lynch and Nick Crofts Med J Aust 2004; 180 (8): 405-407.
Smoking cessation and elective surgery: the cleanest cut [Editorials] Matthew J Peters, Lucy C Morgan and Laurence Gluch Med J Aust 2004; 180 (7): 317-318.
Living with hepatitis C: from self-loathing to advocacy [Personal Perspective] Lisa Waller Med J Aust 2004; 180 (6): 293-294.
Seeking drugs or seeking help? Escalating “doctor shopping” by young heroin users before fatal overdose [Research] Raymond F Martyres, Danielle Clode and Jane M Burns Med J Aust 2004; 180 (5): 211-214.
Doctor shoppers”: at risk by any other name [Editorials] Max Kamien Med J Aust 2004; 180 (5): 204-205.
Should smokers be referred to a smoking-cessation clinic before undergoing elective surgery? [EBM: Trials on Trial] Paul S Myles Med J Aust 2004; 180 (3): 126-127.
Overseas-based online pharmacies: a source of supply for illicit drug users? [For Debate] Bernard N St George, Joseph R Emmanuel and Kate L Middleton Med J Aust 2004; 180 (3): 118-119.
E-drug deals: part of the Wild West world of e-commerce [Editorials] Alan J Gijsbers and Gregory Whelan Med J Aust 2004; 180 (3): 103-104.
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial [Letters] John RM Caplehorn Med J Aust 2003; 179 (10): 557-558.
NSW Alcohol Summit: getting a better grip on our favourite drug [Conference report] Paul S Haber, Katherine M Conigrave and Alex D Wodak Med J Aust 2003; 179 (10): 521-522.
Substance-use disorders and psychological distress among police arrestees [Research] Edward B Heffernan, Joe Finn, John B Saunders and Gerard Byrne Med J Aust 2003; 179 (8): 408-411.
Substance use, psychological distress and crime [Editorials] Toni Makkai Med J Aust 2003; 179 (8): 399-400.
Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial [Public Health] Zane R Macleod, Margaret A Charles, Veronica C Arnaldi and Ian M Adams Med J Aust 2003; 179 (7): 349-352.
The association between licit and illicit drug use and sexuality in young Australian women [Letters] Lynne Hillier, Richard De Visser, Anne M Kavanagh and Ruth P McNair Med J Aust 2003; 179 (6): 326-327.
New pharmacotherapies for alcohol dependence: are they being used and what do they cost? [Letters] Christopher M Doran, Julia E Fawcett, Anthony P Shakeshaft, Marian D Shanahan and Richard P Mattick Med J Aust 2003; 179 (4): 218.
Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase [Letters] Michael Copeman Med J Aust 2003; 179 (2): 119.
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial [General Practice In Action] Amy E Gibson, Christopher M Doran, James R Bell, Anni Ryan and Nicholas Lintzeris Med J Aust 2003; 179 (1): 38-42.
Tobacco control in Australia: what aren't you doing and why aren't you doing it? [Editorials] Dileep G Bal, Donald O Lyman and David F Veneziano Med J Aust 2003; 178 (7): 313-314.
Risk-taking behaviour of young women in Australia: screening for health-risk behaviours [Young Women's Health] Michael R C Carr-Gregg, Kate C Enderby and Sonia R Grover Med J Aust 2003; 178 (12): 601-604.
Fatal intravenous misuse of transdermal fentanyl [Correction] Mark D Reeves and Corinne J Ginifer Med J Aust 2003; 178 (10): 526.
Correction - Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the in [Correction] Matthew G Law and Robert G Batey Med J Aust 2003; 178 (10): 494.
Substance misuse in patients with schizophrenia: a primary care guide [Schizophrenia] Dan I Lubman and Suresh Sundram Med J Aust 2003; 178 (9 Suppl): S71-S75.
Doctor shoppers' rights: privacy or lunacy? [Letters] Max Kamien Med J Aust 2003; 178 (5): 248.
Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase [Editorials] Matthew G Law and Robert G Batey Med J Aust 2003; 178 (5): 197-198.
"Chop-chop" tobacco smoking [Letters] Renee Bittoun Med J Aust 2002; 177 (11/12): 686-687.
Fatal intravenous misuse of transdermal fentanyl [Notable Cases] Mark D Reeves and Corinne J Ginifer Med J Aust 2002; 177 (10): 552-554.
Death and paramethoxyamphetamine — an evolving problem [Letters] Werner Jacobs Med J Aust 2002; 177 (8): 460.
The contribution of airway structure to early childhood asthma [Correction] Karen O McKay and James C Hogg Med J Aust 2002; 177 (7): 396.
Rising cannabis use in Indigenous communities [Letters] Alan R Clough, Sheree Cairney, Paul Maruff and Robert Parker Med J Aust 2002; 177 (7): 395-396.
Cocaine use and cardiovascular complications [Clinical Update] Gabriella Vasica and Christopher C Tennant Med J Aust 2002; 177 (5): 260-262.
Hepatitis C-related discrimination in healthcare [Conference Report] Carla J Treloar, Max N Hopwood and Stuart K Loveday Med J Aust 2002; 177 (5): 233-234.
Street GP [Addiction Medicine—Personal Perspe] Raymond Seidler Med J Aust 2002; 177 (2): 108.
New pharmacotherapies for alcohol dependence [Addiction Medicine — New Drugs, Ol] Robert Graham, Alex D Wodak and Greg Whelan Med J Aust 2002; 177 (2): 103-107.
Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting [Research] Noeline C Latt, Stephen Jurd, Jennie Houseman and Sonia E Wutzke Med J Aust 2002; 176 (11): 530-534.
Death and paramethoxyamphetamine — an evolving problem [Lessons from Practice] Roger W Byard, Nicholas G Rodgers, Ross A James, Chris Kostakis and Andrew M Camilleri Med J Aust 2002; 176 (10): 496.
Is subcutaneous or intramuscular naloxone as effective as intravenous naloxone in the treatment of life-threatening hero [EBM in Action] Jason Wasiak and Ornella Clavisi Med J Aust 2002; 176 (10): 495.
Which substitution pharmacotherapy is most effective in treating opioid dependence? [EBM: Trials on trial] Linda R Gowing, Robert L Ali and Jason M White Med J Aust 2002; 176 (10): 493-494.
The pharmacotherapy of smoking cessation [New Drugs, Old Drugs] Matthew J Peters and Lucy C Morgan Med J Aust 2002; 176 (10): 486-490.
Separating politics and scientific research on heroin prescription [Letters] Alex D Wodak, Alison J Ritter and Charles RR Watson Med J Aust 2002; 176 (10): 449.
In reply: [Letters] Wayne D Hall, Richard P Mattick and Jo Kimber Med J Aust 2002; 176 (9): 450.
Digit loss following misuse of temazepam [Snapsho] Gerald FX Feeney and Harry H Gibbs Med J Aust 2002; 176 (8): 380.
HIV among injecting drug users of Indo-Chinese ethnicity in Victoria [Letters] Jane S Hocking, Peter G Higgs, Cathy M Keenan and Nick Crofts Med J Aust 2002; 176 (4): 191-192.
Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose [Notable Cases] Nicolas C Clark, Nicholas Lintzeris and Peter J Muhleisen Med J Aust 2002; 176 (4): 166-167.
Is bupropion (Zyban) causing deaths? [Letters] Simon C Chapman and Konrad Jamrozik Med J Aust 2002; 176 (3): 134.
How much alcohol is drunk in Australia in excess of the new Australian alcohol guidelines? [Letters] Tim R Stockwell, Penny Heale, Tanya N Chikritzhs, Paul Dietze and Paul Catalano Med J Aust 2002; 176 (2): 91-92.
Breaking the deadlock over an Australian trial [For debate] Wayne D Hall, Jo Kimber and Richard P Mattick Med J Aust 2002; 176 (2): 72-73.
Alcohol and drugs [Medicine] Alex D Wodak Med J Aust 2002; 176 (1): 5.
How many dependent heroin users are there in Australia? [Public Health] Wayne D Hall, Joanne E Ross, Michael T Lynskey, Matthew G Law and Louisa J Degenhardt Med J Aust 2000; 173: 528-531
An analgesic role for cannabinoids [Viewpoint] Christopher W Vaughan and Macdonald J Christie Med J Aust 2000; 173: 270-272
The New South Wales Drug Summit: a view from a local foreign observer [Personal Perspective] Jeffrey H Samet Med J Aust 2000; 173: 264-265
Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? [For Debate] Simon R Lenton and Kim M Hargreaves Med J Aust 2000; 173: 260-263
Alcohol: the good, the bad and the ugly [Editorial] Greg Whelan and Alan T Gijsbers Med J Aust 2000; 173: 231-232
Alcohol and cardiovascular disease: still a research priority? [Editorial] Timothy R Stockwell Med J Aust 2000; 173: 116-117
Is the grass greener? The link between cannabis and psychosis [Viewpoint] Diana R McKay and Christopher C Tennant Med J Aust 2000; 172: 284-286
A pilot study of naltrexone-accelerated detoxification in opioid dependence [Healthcare] James R Bell, Malcolm R Young, Sibyl C Masterman, Amanda Morris, Richard P Mattick and Gabriele Med J Aust 1999; 171: 26-30
Is naltrexone a cure for heroin dependence? [Editorial] Wayne D Hall, Alex Wodak Med J Aust 1999; 171: 9-10
The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not [Viewpoint] Nick Crofts, Campbell K Aitken, John M Kaldor Med J Aust 1999; 170: 220-221
Heroin addiction: the science and ethics of the new treatment pluralism [Viewpoint] Matt D Gaughwin and Philip Ryan Med J Aust 1999; 170: 129-130
Mortality associated with New South Wales methadone programs in 1994: lives lost and saved [Research] John R M Caplehorn and Olaf H Drummer Med J Aust 1999; 170: 104-109
�Acculturating� heroin use [For Debate] Gaughwin Med J Aust 1998; 169: 692-693
Accidental drug toxicity associated with methadone maintenance treatment [Editorial] Robert L Ali and Allan J Quigley Med J Aust 1998; 169: 100-101
Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and h [Research] Nicky Metrebian, William Shanahan, Brian Wells and Gerry V Stimson Med J Aust 1998; 168: 596-600
Prescribing heroin: nothing to fear but fear itself? [Editorial] Alex Wodak Med J Aust 1998; 168: 590-591
Prevalence of Wernicke-Korsakoff syndrome in Australia: has thiamine fortification made a difference? [Research] Clive G Harper, Donna L Sheedy, Ana I Lara, Therese M Garrick, John M Hilton and Jack Raisanen Med J Aust 1998; 168: 542-545
Wernicke's encephalopathy and thiamine fortification of food: time for a new direction? [Editorial] Leslie R Drew, A Stewart Truswell Med J Aust 1998; 168: 535-536
Public health and politics: the demise of the ACT heroin trial [Letter] Christopher J Alroe Med J Aust 1998; 168: 527
Collateral damage from alcohol abuse: the enormous costs to Australia [Editorial] Yen F Tai, John B Saunders, David S Celermajer Med J Aust 1998; 168: 6-7
How the NHMRC got its finger burnt [Medicine and the law] Konrad Jamrozik, Simon Chapman, Alistair Woodward Med J Aust 1997; 167: 372-374
Public health and politics: the demise of the ACT heroin trial [Editorials] Alex D Wodak Med J Aust 1997; 167: 348-349
Ephedrine abuse causing acute myocardial infarction [Notable Case] Jerome G L Cockings and Michael A Brown Med J Aust 1997; 167: 199-200
Hyponatraemia and death after [Notable cases] Michael J A Parr, Heather M Low, Paull Botterill Med J Aust 1997; 166: 136
Hepatitis B and C in New South Wales prisons: prevalence and risk factors [Research] Tony G Butler, Kate A Dolan, Mark J Ferson, Linda M McGuinness, Phillip R Brown, Peter W Robertson Med J Aust 1997; 166: 127
The agony of [Editorials] Jason M White, Felix Bochner, Rodney J Irvine Med J Aust 1997; 166: 117
A cruel and unusual punishment [Editorials] Nick Crofts Med J Aust 1997; 166: 116
The heroin trial we had to have [For Debate] Nick Crofts Med J Aust 1996; 164: 694-695
The heroin trial we had to have [For Debate] Nick Crofts Med J Aust 1996; 164: 694-695
'Acculturating' heroin use [For Debate] Matt D Gaughwin Med J Aust 1996; 164: 692-693
The ACT heroin trial proposal: an overview [For Debate] Gabriele Bammer and Robert M Douglas Med J Aust 1996; 164: 690-692
The ACT heroin trial proposal: an overview [For Debate] Gabriele Bammer and Robert M Douglas Med J Aust 1996; 164: 690-692
Ingredient and nutrition information labelling of alcoholic beverages: do consumers want it? [Letters] Kypros Kypri, Alexandra McManus, Peter M Howat, Bruce R Maycock, Jonathan D Hallett and Tanya N Chikritzhs Med J Aust ; 187 (11/12): 669.